Robert Fulton

Medicine & Life Sciences

1. Genome 100%
2. Mutation 74%
3. Genes 54%
4. Acute Myeloid Leukemia 50%
5. Neoplasms 49%
6. Human Genome 33%
7. Whole Genome Sequencing 30%
8. Atlases 29%
9. Exome 28%
10. Precursor Cell Lymphoblastic Leukemia-Lymphoma 22%
11. Human Chromosomes 18%
12. Genomics 18%
13. Clone Cells 17%
14. High-Throughput Nucleotide Sequencing 16%
15. Chromosomes 16%
16. Myelodysplastic Syndromes 15%
17. Whole Exome Sequencing 15%
18. RNA Sequence Analysis 13%
19. Myeloid Cells 13%
20. Chromosomes, Human, Pair 7 12%
21. Genetic Variation 12%
22. Breast Neoplasms 12%
23. GATA2 Deficiency 11%
24. Population 11%
25. Epigenomics 11%
26. Hematopoietic Stem Cells 10%
27. Nucleotides 10%
28. Retinitis Pigmentosa 10%
29. Proteins 10%
30. Clonal Evolution 9%
31. Genomic Structural Variation 9%
32. Yeast Artificial Chromosomes 9%
33. Single Nucleotide Polymorphism 9%
34. Microbiota 9%
35. Therapeutics 9%
36. Haplotypes 9%
37. Hematopoiesis 8%
38. Neoplasm Genes 8%
39. Datasets 8%
40. Y Chromosome 8%
41. DNA 8%
42. Recurrence 8%
43. Zea mays 8%
44. Sequence Tagged Sites 7%
45. Phenotype 7%
46. Sequence Analysis 7%
47. Glioma 7%
48. DNA Methylation 7%
49. Genome-Wide Association Study 7%
50. Chromosomes, Human, X 6%